Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study

Henny J M Beckers,Florent Aptel,Carroll A B Webers,Elisa Bluwol,José M Martínez-de-la-Casa,Julián García-Feijoó,Yves Lachkar,Carmen D Méndez-Hernández,Isabelle Riss,Hui Shao,Leonard Pinchuk, Raymund Angeles,Omar Sadruddin,Tarek M Shaarawy

Ophthalmology Glaucoma（2022）

引用 32|浏览4

暂无评分

摘要

In this study, mean IOP and glaucoma medication reductions were significant and sustained over 2 years postsurgery. No long-term, sight-threatening AEs were reported. Further studies may confirm potential risk/benefits of higher MMC concentration.

查看译文

关键词

Clinical trial,Glaucoma filtration surgery,MIGS,Primary open-angle glaucoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要